Valo Health
Also: Overjet hires Dr. Teresa Dolan as chief dental officer, Valo Health appoints Dr. Dave Morris as chief medical officer and AliveCor adds four new people to its executive team.
Valo’s flagship product is its Opal Computational Platform, designed to create a new model for drug discovery.
Also: Valo Health closes $300 million for machine learning drug discovery; Blue Note Therapeutics supports its in-development prescription DTx with $26.25 million.
Valo Health’s Opal Computational Platform uses machine learning, cloud computing and real-world data to assist in the drug discovery and development process.